Related Experiment Video

Updated: Dec 7, 2025

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.6K

A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery

Jing-Yan Tian1, Chang-Liang Chi1, Ge Bian1

  • 1Department of Urology, Second Division of The First Hospital of Jilin University, Changchun, People's Republic of China.

Basic & Clinical Pharmacology & Toxicology
|September 29, 2020
PubMed

Insights

Androgen ablation therapy resistance in prostate cancer is complex. Targeting G-protein-coupled receptor pathways, like GRK2, offers new strategies against metastatic castration-resistant prostate cancer (mCRPC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Androgen ablation therapy is a primary treatment for advanced prostate cancer, but resistance develops, leading to metastatic castration-resistant prostate cancer (mCRPC).
  • The molecular mechanisms driving mCRPC and androgen independence are complex and not fully understood.
  • Intracellular signaling pathways, particularly those involving G-protein-coupled receptors (GPCRs), are implicated in cancer progression but their role in mCRPC is poorly defined.

Purpose of the Study:

  • To explore the role of GPCR-mediated pathways in the development of castration-resistant prostate cancer.
  • To investigate the potential of targeting GPCR signaling as a therapeutic strategy for mCRPC.
  • To understand how G-protein-coupled receptor kinase 2 (GRK2) influences prostate cancer cell functions and tumor progression.

Main Methods:

  • Review of existing clinical and preclinical data on GPCR signaling in prostate cancer.
  • Analysis of the role of GRK2 in cellular functions such as proliferation, survival, and motility.
  • Examination of GRK2's involvement in metabolic homeostasis, inflammation, and angiogenesis in tumor contexts.

Main Results:

  • Altered GRK2 levels are observed in various tumors and can promote tumorigenesis and angiogenesis.
  • GPCR-mediated pathways represent potential targets for interfering with major tumor-promoting signals.
  • The specific intracellular signaling pathways of GPCRs contributing to mitogenic acquired resistance in prostate cancer require further elucidation.

Conclusions:

  • Targeting GPCR-mediated pathways, including GRK2, presents novel therapeutic opportunities for overcoming resistance in prostate cancer.
  • Understanding the complex molecular biology of mCRPC is crucial for developing effective treatments.
  • Further research into GPCR signaling in prostate cancer could lead to innovative strategies against advanced disease.
Keywords:
Androgen deprivation therapyAndrogen receptorForkhead boxG-protein receptor kinaseG-protein-coupled receptorMetastatic castration-resistant prostate cancer

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.3K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.1K

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
15.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.5K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
3.4K